Cargando…
Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation
Acute graft-versus-host disease (aGvHD) is the major barrier to the broader use of allogenetic hematopoietic stem cells. However, currently these are no highly specific and efficient drugs. Monotherapy is not sufficient and more efficient and safe therapeutic regimen are urgent need. Studies demonst...
Autores principales: | Jia, Huijie, Zhao, Tiesuo, Ji, Yinghua, Jia, Xiaolong, Ren, Wenjing, Li, Chen, Li, Minming, Xiao, Yali, Wang, Hui, Xu, Kailin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261008/ https://www.ncbi.nlm.nih.gov/pubmed/27906171 http://dx.doi.org/10.1038/cddis.2016.399 |
Ejemplares similares
-
Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use
por: Jia, Huijie, et al.
Publicado: (2017) -
EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation
por: Wang, Weiwei, et al.
Publicado: (2022) -
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
por: Gan, Cailing, et al.
Publicado: (2022) -
Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model
por: Yang, F, et al.
Publicado: (2015) -
Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2016)